Replies to post #2332684 on MOMO'S BREAKOUT BOARD

[BlazingStocks]

$NRXP - NRx remains eligible for an additional $324 million in development and sales milestones, as well as tiered double-digit royalties upon approval and commercialization of NRX-101.
https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nasdaq-nrxp-133000063.html